Global Monkeypox Virus Tests Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Monkeypox Virus Tests Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Monkeypox virus tests are used to determine if a person is infected with the virus that causes monkeypox, which is a type of orthopoxvirus.
Monkeypox Virus Tests report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Monkeypox Virus Tests market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals & Clinics and Diagnostic Laboratories are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Monkeypox Virus Tests industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Monkeypox Virus Tests key companies include Aegis Sciences Corp., Laboratory Corp. of America Holdings, Quest Diagnostics, Inc., Sonic Healthcare Ltd., QIAGEN, Mayo Clinic Laboratories, Chembio Diagnostics, Inc., Sonora Quest Laboratories and Thermo Fisher Scientific, etc. Aegis Sciences Corp., Laboratory Corp. of America Holdings, Quest Diagnostics, Inc. are top 3 players and held % share in total in 2022.
Monkeypox Virus Tests can be divided into Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA) and Others,, etc. Polymerase Chain Reaction (PCR) is the mainstream product in the market, accounting for % share globally in 2022.
Monkeypox Virus Tests is widely used in various fields, such as Hospitals & Clinics, Diagnostic Laboratories and Others,, etc. Hospitals & Clinics provides greatest supports to the Monkeypox Virus Tests industry development. In 2022, global % share of Monkeypox Virus Tests went into Hospitals & Clinics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Monkeypox Virus Tests market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Aegis Sciences Corp.
Laboratory Corp. of America Holdings
Quest Diagnostics, Inc.
Sonic Healthcare Ltd.
QIAGEN
Mayo Clinic Laboratories
Chembio Diagnostics, Inc.
Sonora Quest Laboratories
Thermo Fisher Scientific
BD
Segment by Type
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
Hospitals & Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Monkeypox Virus Tests market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Monkeypox Virus Tests introduction, etc. Monkeypox Virus Tests Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Monkeypox Virus Tests market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Monkeypox Virus Tests report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Monkeypox Virus Tests market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals & Clinics and Diagnostic Laboratories are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Monkeypox Virus Tests industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Monkeypox Virus Tests key companies include Aegis Sciences Corp., Laboratory Corp. of America Holdings, Quest Diagnostics, Inc., Sonic Healthcare Ltd., QIAGEN, Mayo Clinic Laboratories, Chembio Diagnostics, Inc., Sonora Quest Laboratories and Thermo Fisher Scientific, etc. Aegis Sciences Corp., Laboratory Corp. of America Holdings, Quest Diagnostics, Inc. are top 3 players and held % share in total in 2022.
Monkeypox Virus Tests can be divided into Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA) and Others,, etc. Polymerase Chain Reaction (PCR) is the mainstream product in the market, accounting for % share globally in 2022.
Monkeypox Virus Tests is widely used in various fields, such as Hospitals & Clinics, Diagnostic Laboratories and Others,, etc. Hospitals & Clinics provides greatest supports to the Monkeypox Virus Tests industry development. In 2022, global % share of Monkeypox Virus Tests went into Hospitals & Clinics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Monkeypox Virus Tests market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Aegis Sciences Corp.
Laboratory Corp. of America Holdings
Quest Diagnostics, Inc.
Sonic Healthcare Ltd.
QIAGEN
Mayo Clinic Laboratories
Chembio Diagnostics, Inc.
Sonora Quest Laboratories
Thermo Fisher Scientific
BD
Segment by Type
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
Segment by Application
Hospitals & Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Monkeypox Virus Tests market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Monkeypox Virus Tests introduction, etc. Monkeypox Virus Tests Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Monkeypox Virus Tests market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices